Plexus Corp. CEO Sells Over $1.6M in Stock Following RSU Vesting Amidst Other Insider Sales
PLXS sits 97% above its 52-week low of $103.43 on elevated volume (2.0× avg).
Summary
Plexus Corp.'s President and CEO, Todd P. Kelsey, sold approximately $1.67 million worth of common stock in open market transactions after exercising Restricted Stock Units, contributing to a pattern of insider selling.
Key Events · Ownership and Investor Activity · PLXS
-
CEO Sells Shares
President and CEO Todd P. Kelsey sold 8,120 shares of common stock for approximately $1.67 million in open market transactions on February 3, 2026.
-
RSU Vesting and Exercise
The sales followed the vesting and exercise of 31,290 Restricted Stock Units on January 30, 2026, which resulted in the acquisition of common stock.
-
Tax Withholding
A portion of the shares (14,724) were disposed of to cover tax obligations related to the RSU vesting, valued at approximately $2.93 million.
-
Insider Selling Pattern
This transaction contributes to a pattern of insider distribution, with other Form 4 and Form 144 filings indicating additional insider sales around the same period, including a CFO sale on the same day.
Analysis · PLXS · Manufacturing
This Form 4 filing indicates that Plexus Corp.'s President and CEO, Todd P. Kelsey, engaged in a significant open market sale of company stock totaling approximately $1.67 million. This transaction occurred on the same day as other insider selling activity, including a CFO sale, and follows the vesting and exercise of Restricted Stock Units. While some sales are often associated with covering taxes from RSU vesting, the additional open market sale of this magnitude by a key executive, especially with the stock trading near its 52-week high, could be interpreted as profit-taking or a signal of reduced conviction. Investors should note this as part of a broader pattern of insider distribution.
At the time of this filing, PLXS was trading at $203.78 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $103.43 to $208.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.